Dinney CP - Search Results

1

Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.

Kassouf W, Dinney CP, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, Adam L. Kassouf W, et al. Among authors: dinney cp. Cancer Res. 2005 Nov 15;65(22):10524-35. doi: 10.1158/0008-5472.CAN-05-1536. Cancer Res. 2005. PMID: 16288045

2

Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.

Dinney CP, Bucana CD, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ. Dinney CP, et al. Cancer Res. 1991 Jul 15;51(14):3741-7. Cancer Res. 1991. PMID: 1905975

3

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Pollack A, et al. Among authors: dinney cp. Cancer. 1994 Nov 15;74(10):2819-27. doi: 10.1002/1097-0142(19941115)74:10<2819::aid-cncr2820741013>3.0.co;2-l. Cancer. 1994. PMID: 7954243 Clinical Trial.

4

Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.

Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT. Kleinerman DI, et al. Among authors: dinney cp. Cancer Res. 1996 Aug 1;56(15):3431-5. Cancer Res. 1996. PMID: 8758907

5

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.

Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ. Dinney CP, et al. Cancer Res. 1998 Feb 15;58(4):808-14. Cancer Res. 1998. PMID: 9485039

6

p53 and RB expression predict progression in T1 bladder cancer.

Grossman HB, Liebert M, Antelo M, Dinney CP, Hu SX, Palmer JL, Benedict WF. Grossman HB, et al. Among authors: dinney cp. Clin Cancer Res. 1998 Apr;4(4):829-34. Clin Cancer Res. 1998. PMID: 9563875

7

Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.

Dinney CP, Parker C, Dong Z, Fan D, Eve BY, Bucana C, Radinsky R. Dinney CP, et al. Clin Cancer Res. 1997 Feb;3(2):161-8. Clin Cancer Res. 1997. PMID: 9815668

8

Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.

Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D, Fidler IJ. Dong Z, et al. Among authors: dinney cp. Cancer Res. 1999 Feb 15;59(4):872-9. Cancer Res. 1999. PMID: 10029078

9

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R, Dinney CP. Perrotte P, et al. Among authors: dinney cp. Clin Cancer Res. 1999 Feb;5(2):257-65. Clin Cancer Res. 1999. PMID: 10037173

10

Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.

Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP. Balbay MD, et al. Among authors: dinney cp. Clin Cancer Res. 1999 Apr;5(4):783-9. Clin Cancer Res. 1999. PMID: 10213213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters